You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Angle aims to show that clinicians can determine HER-2 status by subjecting harvested circulating tumor cells to fluorescence in situ hybridization (FISH).
The new guidelines said ROS1, KRAS, BRAF, MET, RET, and HER2 should be included in targeted and expanded panels.
Through the new lab, NeoGenomics can work with pharmaceutical clients through the different phases of drug development, including the development of companion diagnostics.
The acquisition allows Sysmex to enter the cytogenetics market and strengthens its technology base in molecular genetics, while expanding its life science business.
A research team led by investigators at Rockefeller University has developed a new method for detecting microRNAs in tissue samples, demonstrating its ability to differentiate skin cancer types based on tumor-specific miRNA signatures.